Cargando…

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer

Few studies have reported whether nutrients in the tumor microenvironment can regulate the expression of PD-L1. Since tumor cells are often situated in a low-glutamine environment, we investigated PD-L1 expression under glutamine deprivation in bladder cancer cells. PD-L1 expression and the activati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liping, Xu, Ting, Yang, Xuecheng, Liang, Zhijuan, Zhang, Jisheng, Li, Dan, Chen, Yuanbin, Ma, Guofeng, Wang, Yonghua, Liang, Ye, Niu, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602840/ https://www.ncbi.nlm.nih.gov/pubmed/34805266 http://dx.doi.org/10.3389/fmolb.2021.687305

Ejemplares similares

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
por: Wang, Liping, et al.
Publicado: (2018)

Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis
por: Sun, Ningchuan, et al.
Publicado: (2019)

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
por: Ma, Guofeng, et al.
Publicado: (2021)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue
por: Sommer, Ulrich, et al.
Publicado: (2022)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2021)

Correction: Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2023)

Structural and Functional Insights into Small, Glutamine-Rich, Tetratricopeptide Repeat Protein Alpha
por: Roberts, Joanna D., et al.
Publicado: (2015)

Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
por: Zhang, Zhilei, et al.
Publicado: (2023)

Glutamine Hydrolysis by Imidazole Glycerol Phosphate Synthase Displays Temperature Dependent Allosteric Activation
por: Lisi, George P., et al.
Publicado: (2018)

New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family
por: Filippova, Irina Y., et al.
Publicado: (2020)

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
por: Guo, Lihao, et al.
Publicado: (2021)

Up-Regulating ERIC by CRISPR-dCas9-VPR Inhibits Cell Proliferation and Invasion and Promotes Apoptosis in Human Bladder Cancer
por: Yang, Jiangeng, et al.
Publicado: (2021)

A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
por: Fan, Zhongyuan, et al.
Publicado: (2019)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Asparagine and Glutamine Side-Chains and Ladders in HET-s(218–289) Amyloid Fibrils Studied by Fast Magic-Angle Spinning NMR
por: Wiegand, Thomas, et al.
Publicado: (2020)

Investigating the role of GLUL as a survival factor in cellular adaptation to glutamine depletion via targeted stable isotope resolved metabolomics
por: Bayram, Șafak, et al.
Publicado: (2022)

Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
por: Liang, Yimin, et al.
Publicado: (2022)

TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs
por: Wang, Kai, et al.
Publicado: (2021)

Injecting Immunosuppressive M2 Macrophages Alleviates the Symptoms of Periodontitis in Mice
por: Miao, Yibin, et al.
Publicado: (2020)

Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

Corrigendum: Injecting Immunosuppressive M2 Macrophages Alleviates the Symptoms of Periodontitis in Mice
por: Miao, Yibin, et al.
Publicado: (2022)

Extracellular Vesicles and Their Associated miRNAs as Potential Biomarkers in Intracranial Aneurysm
por: Li, Yuman, et al.
Publicado: (2022)

Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
por: Tang, Xingxing, et al.
Publicado: (2020)

Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer
por: Yi, Kezhen, et al.
Publicado: (2021)

Neuronal ferroptosis after intracerebral hemorrhage
por: Ren, Siying, et al.
Publicado: (2022)

Investigating the Role of the N-Terminal Loop of PD-1 in Binding Process Between PD-1 and Nivolumab via Molecular Dynamics Simulation
por: Liu, Wenping, et al.
Publicado: (2020)

RNA-Seq Technology Reveals the Mechanism of SDT Combined With Novel Nanobubbles Against HCC
por: Shang, Haitao, et al.
Publicado: (2022)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
por: Sajjadi, Elham, et al.
Publicado: (2022)

Effect of naturally-occurring mutations on the stability and function of cancer-associated NQO1: Comparison of experiments and computation
por: Pacheco-Garcia, Juan Luis, et al.
Publicado: (2022)

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
por: Zhang, Zhao, et al.
Publicado: (2023)

Perspective: Humanized Pig Models of Bladder Cancer
por: Segatto, Natália Vieira, et al.
Publicado: (2021)

Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer via Bcl-2
por: Wang, Huan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2besbhot39dmtptpmu15jl3b6